Brief: Centessa Pharmaceuticals Says Prices Upsized Underwritten Public Offering Of 15.3 Mln Of American Depositary Shares, At $14.75 Per ADS
Sept 12 (Reuters) - Centessa Pharmaceuticals PLC
260y.F :
* CENTESSA PHARMACEUTICALS - PRICING OF UPSIZED UNDERWRITTEN
PUBLIC OFFERING OF 15.3 MILLION OF AMERICAN DEPOSITARY SHARES,
AT $14.75 PER ADS
Source text for Eikon: ID:nGNX4W2x9p
Further company coverage: 260y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Centessa Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Acquisition Of Centessa By Lilly Approved By The High Court Of Justice Of England And Wales
Street View: Lilly's $7.8 billion Centessa buyout validates sleep‑drug market
Press Digest: New York Times business news - April 1